E-LIB Suche - Ergebnisse für: Link, John O

1

Discovery of Hepatitis B Virus Surface Antigen Suppressor G..:

Kato, Darryl ; Choy, Regina Wai-Yan ; Canales, Eda...
ACS Medicinal Chemistry Letters. 15 (2024) 4 - p. 546-554 , 2024

Link: https://doi.org/10.1021/..

2

Clinical targeting of HIV capsid protein with a long-acting..:

Link, John O. ; Rhee, Martin S. ; Tse, Winston C....
Nature. 584 (2020) 7822 - p. 614-618 , 2020

Link: https://doi.org/10.1038/..

3

Discovery of velpatasvir (GS-5816): A potent pan-genotypic ..:

Link, John O. ; Taylor, James G. ; Trejo-Martin, Alejandra...
Bioorganic & Medicinal Chemistry Letters. 29 (2019) 16 - p. 2415-2427 , 2019

Link: https://doi.org/10.1016/..

4

The Discovery of Ledipasvir (GS-5885): The Potent Once-Dail..:

, In: Topics in Medicinal Chemistry; HCV: The Journey from Discovery to a Cure,

Link, John O. - p. 57-80 , 2019

Link: https://doi.org/10.1007/..

5

Discovery of the pan-genotypic hepatitis C virus NS3/4A pro..:

Taylor, James G. ; Zipfel, Sheila ; Ramey, Kyla...
Bioorganic & Medicinal Chemistry Letters. 29 (2019) 16 - p. 2428-2436 , 2019

Link: https://doi.org/10.1016/..

6

The Discovery of Velpatasvir (GS-5816): The Potent Pan-Geno..:

, In: Topics in Medicinal Chemistry; HCV: The Journey from Discovery to a Cure,

Link, John O. - p. 81-110 , 2019

Link: https://doi.org/10.1007/..

7

539. GS-CA2: A Novel, Potent, and Selective First-In-class ..:

Zheng, Jim ; Yant, Stephen R ; Ahmadyar, Shekeba...
Open Forum Infectious Diseases. 5 (2018) suppl_1 - p. S199-S200 , 2018

Link: https://doi.org/10.1093/..

8

Correction to Discovery of Ledipasvir (GS-5885): A Potent, ..:

Link, John O. ; Taylor, James G. ; Xu, Lianhong...
Journal of Medicinal Chemistry. 59 (2016) 16 - p. 7696-7696 , 2016

Link: https://doi.org/10.1021/..

9

Direct Binding of Ledipasvir to HCV NS5A: Mechanism of Resi..:

Kwon, Hyock Joo ; Xing, Weimei ; Chan, Katie...
PLOS ONE. 10 (2015) 4 - p. e0122844 , 2015

Link: https://doi.org/10.1371/..

10

Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Ora..:

Link, John O. ; Taylor, James G. ; Xu, Lianhong...
Journal of Medicinal Chemistry. 57 (2014) 5 - p. 2033-2046 , 2014

Link: https://doi.org/10.1021/..

11

A phase 1, randomized, placebo-controlled, 3-day, dose-rang..:

Lawitz, Eric J. ; Gruener, Daniel ; Hill, John M....
Journal of Hepatology. 57 (2012) 1 - p. 24-31 , 2012

Link: https://doi.org/10.1016/..

12

Metal mediated protease inhibition: design and synthesis of..:

Dhanak, Dashyant ; Burton, George ; Christmann, Lisa T...
Bioorganic & Medicinal Chemistry Letters. 10 (2000) 20 - p. 2279-2282 , 2000

Link: https://doi.org/10.1016/..

13

Asymmetric Synthesis and Stereochemical Assignment of RS-97..:

Smith, David B. ; Waltos, Ann Marie ; Loughhead, David G....
The Journal of Organic Chemistry. 61 (1996) 6 - p. 2236-2241 , 1996

Link: https://doi.org/10.1021/..

14

Trapping of an IMP Dehydrogenase−Substrate Covalent Interme..:

Link, John O. ; Straub, Kenneth
Journal of the American Chemical Society. 118 (1996) 8 - p. 2091-2092 , 1996

Link: https://doi.org/10.1021/..

15

A mechanistic and structural analysis of the basis for high..:

Corey, E.J. ; Link, John O. ; Bakshi, Raman K.
Tetrahedron Letters. 33 (1992) 47 - p. 7107-7110 , 1992

Link: https://doi.org/10.1016/..